• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tau-induced neurodegeneration: mechanisms and targets.tau蛋白诱导的神经退行性变:机制与靶点
Neurosci Bull. 2014 Apr;30(2):346-58. doi: 10.1007/s12264-013-1414-z. Epub 2014 Apr 15.
2
Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.阿尔茨海默病及相关tau蛋白病中tau蛋白诱导神经退行性变的机制。
Curr Alzheimer Res. 2008 Aug;5(4):375-84. doi: 10.2174/156720508785132307.
3
Post-translational modifications of tau protein in Alzheimer's disease.阿尔茨海默病中tau蛋白的翻译后修饰
J Neural Transm (Vienna). 2005 Jun;112(6):813-38. doi: 10.1007/s00702-004-0221-0. Epub 2004 Oct 27.
4
Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.tau蛋白过度磷酸化会导致细胞凋亡逃逸,并引发阿尔茨海默病中的神经退行性变。
Neurosci Bull. 2014 Apr;30(2):359-66. doi: 10.1007/s12264-013-1415-y. Epub 2014 Mar 14.
5
Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.tau蛋白无法正常调节神经元微管动力学:一种tau蛋白可能介导神经元细胞死亡的功能丧失机制。
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):268-79. doi: 10.1016/j.bbadis.2004.07.002.
6
Tau pathology in Alzheimer disease and other tauopathies.阿尔茨海默病及其他tau蛋白病中的tau蛋白病变
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210. doi: 10.1016/j.bbadis.2004.09.008.
7
Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation.磷酸化和底物调节对tau促进微管生长和成核能力的差异影响。
J Biol Chem. 1994 Apr 22;269(16):11776-82.
8
Tau protein modifications and interactions: their role in function and dysfunction.Tau蛋白修饰与相互作用:它们在功能及功能障碍中的作用
Int J Mol Sci. 2014 Mar 18;15(3):4671-713. doi: 10.3390/ijms15034671.
9
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.tau 异常过度磷酸化:部位、调节及神经原纤维变性的分子机制。
J Alzheimers Dis. 2013;33 Suppl 1:S123-39. doi: 10.3233/JAD-2012-129031.
10
Tau-induced neurodegeneration: a clue to its mechanism.tau蛋白诱导的神经退行性变:其机制的线索
J Alzheimers Dis. 2005 Dec;8(3):223-6. doi: 10.3233/jad-2005-8301.

引用本文的文献

1
[I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus-Subiculum and Evaluation of Drug Effects.[I]用于tau成像的IPPI:对死后人类阿尔茨海默病海马-下托的结合研究及药物效果评估。
Synapse. 2025 Jul;79(4):e70024. doi: 10.1002/syn.70024.
2
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases.适配体作为衰老及衰老相关疾病的诊断和治疗剂
Biosensors (Basel). 2025 Apr 5;15(4):232. doi: 10.3390/bios15040232.
3
Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction.葡萄糖富集缩短了表达人tau蛋白的秀丽隐杆线虫的寿命并促进tau蛋白磷酸化,不受O-β-氨基葡萄糖酰化诱导的影响。
J Mol Med (Berl). 2025 Mar;103(3):327-338. doi: 10.1007/s00109-025-02522-3. Epub 2025 Feb 10.
4
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics.评估基于脲和硫脲的小分子对神经退行性疾病治疗的α-突触核蛋白和 Tau 抗聚集活性。
ACS Chem Neurosci. 2024 Nov 6;15(21):3915-3931. doi: 10.1021/acschemneuro.4c00282. Epub 2024 Oct 22.
5
P-tau217 as a Reliable Blood-Based Marker of Alzheimer's Disease.磷酸化tau蛋白217作为阿尔茨海默病可靠的血液标志物
Biomedicines. 2024 Aug 13;12(8):1836. doi: 10.3390/biomedicines12081836.
6
Mitophagy in Alzheimer's Disease: A Bibliometric Analysis from 2007 to 2022.阿尔茨海默病中的线粒体自噬:2007年至2022年的文献计量分析
J Alzheimers Dis Rep. 2024 Jan 29;8(1):101-128. doi: 10.3233/ADR-230139. eCollection 2024.
7
Binding Parameters of [C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents.微管成像PET放射性药物[C]MPC - 6827在啮齿动物中的结合参数
Pharmaceuticals (Basel). 2023 Mar 27;16(4):495. doi: 10.3390/ph16040495.
8
Deregulated Transcription and Proteostasis in Adult Knockout Mouse.成年 敲除小鼠中的转录失调和蛋白质稳态失衡。
Int J Mol Sci. 2023 Mar 31;24(7):6559. doi: 10.3390/ijms24076559.
9
Death-associated protein kinase 1 is associated with cognitive dysfunction in major depressive disorder.死亡相关蛋白激酶1与重度抑郁症中的认知功能障碍有关。
Neural Regen Res. 2023 Aug;18(8):1795-1801. doi: 10.4103/1673-5374.361532.
10
Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model.通过个性化数学模型优化阿尔茨海默病的抗β淀粉样蛋白治疗。
PLoS Comput Biol. 2022 Sep 2;18(9):e1010481. doi: 10.1371/journal.pcbi.1010481. eCollection 2022 Sep.

本文引用的文献

1
The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.挽救微管依赖性运输可恢复帕金森病中的线粒体功能。
Biochim Biophys Acta. 2014 Jan;1842(1):7-21. doi: 10.1016/j.bbadis.2013.10.003. Epub 2013 Oct 11.
2
Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.Tau蛋白清除机制及其在阿尔茨海默病发病机制中的可能作用。
Front Neurol. 2013 Sep 3;4:122. doi: 10.3389/fneur.2013.00122.
3
SUMO and Alzheimer's disease.SUMO 与阿尔茨海默病。
Neuromolecular Med. 2013 Dec;15(4):720-36. doi: 10.1007/s12017-013-8257-7. Epub 2013 Aug 25.
4
Hyperphosphorylation-induced tau oligomers.过度磷酸化诱导的 tau 寡聚物。
Front Neurol. 2013 Aug 15;4:112. doi: 10.3389/fneur.2013.00112. eCollection 2013.
5
Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.tau蛋白中KXGS基序的乙酰化是调节tau蛋白聚集和清除的关键决定因素。
Hum Mol Genet. 2014 Jan 1;23(1):104-16. doi: 10.1093/hmg/ddt402. Epub 2013 Aug 19.
6
Expression of Alzheimer-like pathological human tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster.阿尔茨海默病样病理人类 tau 的表达导致黑腹果蝇行为运动和嗅觉学习缺陷。
J Alzheimers Dis. 2013;37(3):539-50. doi: 10.3233/JAD-130617.
7
Oxidation and ubiquitination in neurodegeneration.氧化和泛素化在神经退行性变中的作用。
Exp Biol Med (Maywood). 2013 May;238(5):519-24. doi: 10.1177/1535370213488484.
8
NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.NAP(达文肽)可改变严重神经退行性变小鼠模型中的疾病进展:防止轴突运输损伤。
Neurobiol Dis. 2013 Aug;56:79-94. doi: 10.1016/j.nbd.2013.04.012. Epub 2013 Apr 28.
9
Origins of amyloid-β.淀粉样β的起源。
BMC Genomics. 2013 Apr 30;14:290. doi: 10.1186/1471-2164-14-290.
10
Disease-modified glycogen synthase kinase-3β intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model.褪黑素对疾病修饰型糖原合酶激酶-3β的干预作用可阻止阿尔茨海默病动物模型的病理和记忆缺陷。
Neurobiol Aging. 2013 Jun;34(6):1555-63. doi: 10.1016/j.neurobiolaging.2012.12.010. Epub 2013 Feb 10.

tau蛋白诱导的神经退行性变:机制与靶点

Tau-induced neurodegeneration: mechanisms and targets.

作者信息

Beharry Cindy, Cohen Leah S, Di Jing, Ibrahim Kawsar, Briffa-Mirabella Susan, Alonso Alejandra del C

机构信息

Department of Biology and Center for Developmental Neuroscience, College of Staten Island, Graduate Center, The City University of New York, Staten Island, NY, 10314, USA.

出版信息

Neurosci Bull. 2014 Apr;30(2):346-58. doi: 10.1007/s12264-013-1414-z. Epub 2014 Apr 15.

DOI:10.1007/s12264-013-1414-z
PMID:24733656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5562659/
Abstract

The accumulation of hyperphosphorylated tau is a common feature of several dementias. Tau is one of the brain microtubule-associated proteins. Here we discuss tau's functions in microtubule assembly and stabilization and with regard to its interactions with other proteins. We describe and analyze important post-translational modifications: hyperphosphorylation, ubiquitination, glycation, glycosylation, nitration, polyamination, proteolysis, acetylation, and methylation. We discuss how these post-translational modifications can alter tau's biological function. We analyze the role of mitochondrial health in neurodegeneration. We propose that microtubules could be a therapeutic target and review different approaches. Finally, we consider whether tau accumulation or its conformational change is related to tau-induced neurodegeneration, and propose a mechanism of neurodegeneration.

摘要

高度磷酸化tau蛋白的积累是几种痴呆症的共同特征。Tau是一种脑微管相关蛋白。在此,我们讨论tau在微管组装和稳定中的功能,以及它与其他蛋白质的相互作用。我们描述并分析重要的翻译后修饰:高度磷酸化、泛素化、糖基化终产物形成、糖基化、硝化、多胺化、蛋白水解、乙酰化和甲基化。我们讨论这些翻译后修饰如何改变tau的生物学功能。我们分析线粒体健康在神经退行性变中的作用。我们提出微管可能是一个治疗靶点,并综述不同的方法。最后,我们考虑tau积累或其构象变化是否与tau诱导的神经退行性变有关,并提出一种神经退行性变的机制。